Oddo BHF - Virbac SA (VIRP) Virbac : CA T3 : organique en amélioration – Guidances relevées – OC 225 €

Report

Oddo BHF

Christophe-Raphaël Ganet

Virbac : CA T3 : organique en amélioration – Guidances relevées – OC 225 €

>T3 : impact devises plus sensible, mais organique meilleure - Le CA T3 publié ressort à 235,6 M€, +0,9% (+6,8% à tcc et +11,1% hors Sentinel). La forte dépréciation de certaines devises (BRL, MXP, ZAR, INR) a sensiblement pesé sur T3. Hors impact de la cession de Sentinel aux USA, toutes les zones sont toutefois en croissance en comparaison de la même période en 2019.A fin septembre, le CA atteint 714 M€ et 676 M€ hors Sentinel soit +3,3% (+6,8% lfl.) : l...

15/10/2020 4 FR

Underlying

Virbac SA

Virbac is an independent veterinary pharmaceutical laboratory. Co. develops and provides veterinarians and farmers with medicines and vaccines that improve the health of food producing animals. Co. markets a range of products designed for pets and livestock. It offers seven types of products for companion animals (Parasiticides, Immunology, Antibiotics/dermatology, Specialties, Equine, Specialized pet food and Other products), and four types of products for food producing animals (Bovine parasiticides, Bovine products (excluding parasiticides), Pig/poultry antibiotics and Other products). Co. markets its products in the ethical (veterinarian) and OTC markets.

See profile

FR0000031577 Euronext Paris France

Provider

Oddo BHF

Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

See profile

Analysts

Christophe-Raphaël Ganet

Other Reports on these Companies

Oddo BHF

ODDO BHF Small & MIDCAP MORNING NEWS - 04/17/2024 Date Performance since listing Date Performance since listing

NEXT can claim the leading position in the UK fashion category. Moreover, the company managed the transition from offline to online comparatively well. However, top-line growth should remain at 4% a year until 2026 as the business outside the UK is too small. The operating margin should decrease 40bp to 17.6% on higher wages and general Opex inflation. We initiate coverage with a Neutral rating and a TP of 8,900p (based on a peer group and DCF). - ...

22h / 31m 22h / 31m 1 EN

Oddo BHF

ODDO BHF Small & MIDCAP MORNING NEWS - 17/04/2024 Date Performance depuis l’entrée Date Performance depuis l’entrée

22h / 37m 22h / 37m 1 FR

Oddo BHF

Virbac : Q1 2024 revenues: at the upper end of expectations, ahead of guidance

>Q1 +9.7% organically (vs +4.9% over FY 2023) - Q1 revenues at € 345.7m, up 9.8% (+10.8% cc). By species, companion animals delivered strong growth of 16.2% LfL, while livestock revenues were up 4.1% cc (+1.2% LfL). Europe posted growth of 12.5% cc, driven by solid performances in central and eastern Europe (+34.9% LfL) and northern Europe (+23.8% cc). The US recorded the group's strongest growth (+28.4% cc), unlike Latin America, which turned in a more mixed per...

23h / 31m 23h / 31m 1 EN

Carmila : Q1 2024 operational performance positive notably with excellent commercial momentum

>Leading indicators confirm the attractiveness of Carmilla’s shopping centres - Carmila's Q1 2024 operational performance (i.e. net rental income of € 87.4m vs € 88.8m est., +1.1% y-o-y; +4.0% at constant scope) reflects the continued positive trend of the group’s local shopping centres:Retailer sales up 2% y-o-y in Q1 2024. This performance illustrates the resilience of the retailers’ activity with an increase in sales that is close to inflation (sales +1.7% in ...

1m 1m 1 EN

Fatma Agnès Hamdani

Fatma Agnès Hamdani

Marie Brizard Wine & Spirits : Des résultats 2023 meilleurs qu’attendu. Sans surprise le message est mesuré sur les perspectives dans un marché des spiritueux qui se normalise

>UN EBITDA en hausse de 12.2% à 13.1 M€ vs 12.4 M€e et un RNpg positif de 8.7 M€ vs 7.2 M€e - MBWS a publié hier soir des résultats au-dessus de nos attentes. L’EBITDA ressort en hausse de 12.2% à 13.1 M€ contre 12.4 M€ attendus pour un CA déjà publié de 194.2 M€ (+7.1% en publié et 7.2% en organique) La marge brute reste quasi stable à 70.7M€, impliquant une baisse du taux de marge brut de 270 pb à 36.4%. L’inflation des matières premières et du prix de l’énergie ai...

7m 7m 1 FR

Martin Marandon-Carlhian ... (+2)

Martin Marandon-Carlhian
Stephane Houri

ASML : Weak order intake in Q1 (TSMC absent again, not set to be on the sidelines for long), but structural story remains unchanged

>Subdued Q1 24 orders, but this does not change the structural story, and we maintain our Outperform rating and € 1,100 target price - ASML yesterday reported better than expected Q1 24 results (EPS better, despite sales falling short), but importantly posted orders of € 3.6bn, well short of the consensus, due to TMSC’s virtual absence from the backlog this quarter (again). But the group confirmed 2024 is set to be a stable year, with H2 showing growth, but 2025 shou...

7m 7m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Virbac : CA T3 : organique en amélioration – Guidances relevées – OC 225 €

ODDO BHF Small & MIDCAP MORNING NEWS - 04/17/2024 Date Performance since listing Date Performance since listing

ODDO BHF Small & MIDCAP MORNING NEWS - 17/04/2024 Date Performance depuis l’entrée Date Performance depuis l’entrée

Virbac : Q1 2024 revenues: at the upper end of expectations, ahead of guidance

Carmila : Q1 2024 operational performance positive notably with excellent commercial momentum

Marie Brizard Wine & Spirits : Des résultats 2023 meilleurs qu’attendu. Sans surprise le message est mesuré sur les perspectives dans un marché des spiritueux qui se normalise

ASML : Weak order intake in Q1 (TSMC absent again, not set to be on the sidelines for long), but structural story remains unchanged

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe